Description
Lazolvan Solution for Inhalation 15 mg/2 ml. 100 ml
Ingredients:
Lazolvan solution for inhalation contains 15 mg of the active ingredient ambroxol hydrochloride per 2 ml.
Mechanism of Action:
Ambroxol hydrochloride, the active ingredient in Lazolvan solution, acts as a mucolytic agent by stimulating the production of pulmonary surfactant and enhancing the activity of ciliary epithelium. This leads to decreased viscosity of mucus in the respiratory tract, facilitating mucus clearance and improving airway patency.
Pharmacological Properties:
Ambroxol hydrochloride exhibits mucolytic, expectorant, and secretomotoric properties. It enhances the production of serous mucus in the respiratory tract, which aids in the clearance of viscous mucus, thereby promoting effective coughing and expectoration.
Indications for Use:
Lazolvan solution for inhalation is indicated for the treatment of respiratory conditions associated with viscid mucus, including acute and chronic bronchitis, bronchiectasis, and other pulmonary disorders that necessitate improved mucus clearance for symptom relief and enhanced lung function.
Contraindications:
Avoid using Lazolvan solution for inhalation if you have a known hypersensitivity to ambroxol hydrochloride or any other components of the formulation. Consult a healthcare professional for suitable alternatives in such cases.
Side Effects:
Common side effects of Lazolvan solution may include gastrointestinal disturbances, such as nausea and vomiting, as well as allergic reactions like skin rashes or itching. In rare cases, bronchospasm or anaphylaxis may occur. Discontinue use and seek medical attention if any adverse reactions manifest.
Usage Instructions:
For inhalation purposes only, dilute Lazolvan solution with normal saline solution before administration. Utilize a nebulizer to facilitate inhalation of the medication. Follow the dosage regimen and administration guidelines as prescribed by your healthcare provider for optimal therapeutic outcomes.
Benefits Compared to Analogues:
Lazolvan solution offers the advantage of targeted mucolytic therapy with ambroxol hydrochloride, a well-established agent for mucus clearance in respiratory disorders. Its efficacy in improving lung function and symptom management has been demonstrated in clinical studies, distinguishing it as a reliable choice for respiratory care.
Suitable Patient Groups:
Lazolvan solution is suitable for use in both pediatric and geriatric populations, under appropriate medical supervision. Children and elderly individuals with respiratory conditions requiring enhanced mucus clearance can benefit from the therapeutic effects of ambroxol hydrochloride in Lazolvan solution.
Storage and Shelf Life:
Store Lazolvan solution in a cool, dry place away from direct sunlight. Ensure proper sealing of the container after each use. Check the expiration date on the packaging and do not use the solution beyond the specified shelf life to maintain its efficacy and safety.
Packaging Description:
Lazolvan solution is available in a 100 ml container for inhalation use. The packaging is designed to maintain the integrity of the solution and ensure convenient and accurate dosing for patients. Refer to the product label for detailed instructions on usage and storage.
